Japan Marks 8th Anniversary of March 2011 Disaster
Tokyo, March 11 (Jiji Press)--Japan marked the eighth anniversary on Monday of the March 2011 earthquake and tsunami, offering prayers for the victims of the catastrophe and renewing resolve to a
Tokyo, March 11 (Jiji Press)--Japan marked the eighth anniversary on Monday of the March 2011 earthquake and tsunami, offering prayers for the victims of the catastrophe and renewing resolve to a
Tokyo, March 11 (Jiji Press)--Japan marked the eighth anniversary on Monday of the March 2011 earthquake and tsunami, offering prayers for the victims of the catastrophe and renewing resolve to a
Tokyo, March 8 (Jiji Press)--The Japanese government on Friday adopted a bill to add equipment necessary for self-driving, including cameras and radars to monitor surrounding traffic, to the sco
Tokyo, March 8 (Jiji Press)--The Japanese government on Friday adopted a bill to add equipment necessary for self-driving, including cameras and radars to monitor surrounding traffic, to the sco
Tokyo, March 8 (Jiji Press)--The Japanese government on Friday adopted a bill to add equipment necessary for self-driving, including cameras and radars to monitor surrounding traffic, to the sco
Tokyo, March 8 (Jiji Press)--The Japanese government on Friday adopted a bill to add equipment necessary for self-driving, including cameras and radars to monitor surrounding traffic, to the sco
Tokyo, March 8 (Jiji Press)--The Japanese government on Friday adopted a bill to add equipment necessary for self-driving, including cameras and radars to monitor surrounding traffic, to the sco
Kyoto, March 8 (Jiji Press)--A Japanese team has said it succeeded in producing induced pluripotent stem, or iPS, cells with low rejection risk by using the technology of genome editing.
Kyoto, March 8 (Jiji Press)--A Japanese team has said it succeeded in producing induced pluripotent stem, or iPS, cells with low rejection risk by using the technology of genome editing.
Kyoto, March 8 (Jiji Press)--A Japanese team has said it succeeded in producing induced pluripotent stem, or iPS, cells with low rejection risk by using the technology of genome editing.